SUPPLIER SeraCare

SeraCare

In 2015, SeraCare expanded their R&D facility and announced the formation of a new ''Precision Medicine' business unit focused on the development of technologies and products to enable the safe and effective expansion of precision medicine-driven diagnostics.

Since then, novel products for oncology, reproductive health, infectious disease and inherited disease have emerged from the SeraCare pipeline to support our clients’ development and validation efforts for precision medicine diagnostics. During this time, Seraseq technology was introduced to develop high-quality reference materials for next-generation sequencing applications.

SeraCare – New Tools for Clinical Genomics Assay

Next-generation sequencing (NGS) has revolutionized the field of genomics and how in vitro diagnostic (IVD) test developers, laboratories, and clinicians are diagnosing, treating, and monitoring disease. Before successfully launching a clinical assay, platform, or service, the tests must undergo rigorous development and thorough validation to ensure accuracy of the result.

SeraCare’s Seraseq™ comprehensive solution pairs highly consistent, quantitative, and highly multiplexed reference materials with easy-to-use software to greatly speed and simplify the capture and tracking of QC metrics.

Wide Range of Reference Materials

  • Oncology
  • Reproductive health
  • Inherited disease
  • Infectious disease

For Every Phase of Clinical NGS Assay

  • Assay Development
  • Assay Validation
  • Laboratory QC

Clinically Relevant Formats

  • Proprietary technology for the most patient-like reference materials
  • FFPE cell lines to monitor and optimize your entire assay workflow
  • Expedite development and validation with purified mutation DNA and RNA mixes.

 Actionable Variants

  • Expert-designed constructs with a mix of common, rare, and challenging variants
  • Range of variant types includes single nucleotide variants (SNVs), insertion-deletion mutations (INDELs), structural rearrangements (CNVs), and gene fusions
  • Seraseq biosynthetic technology can precisely modulate allele frequency, gene copy numbers, and fusion events for accurate assessment of assay LOD.

Consistent Reference Material

  • Highly multiplexed material with up to 40 variants in a single sample to maximize data output from each sequencing run
  • Digital PCR ensures precise quantitation
  • Manufactured in GMP-compliant and ISO 13485-certified facilities for consistency across time and material lots.
Close filters
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
1 From 2
Item No. Short Description Content
0720-0172 Seraseq® Trisomy 18 Female Matched Reference Material VIAL (1 ml at 20 ng/ ml)
0710-1031 Seraseq™ FFPE NTRK Fusion RNA Reference Material 1 FFPE Curl / Tube
0740-0026 Seraseq™ HIV DR & Tropism RF v2 (5x10^4 viral copies, MF 1/5/20%) 1x1.0 ml
0740-0025 Seraseq™ HIV DR & Tropism RF v2 (5x10^4 viral copies, MF 40%) 1x1.0 ml
0740-0021 Seraseq™ Cardiomyopathy Reference Mat. Purified DNA AF 50% VIAL (200 uL at 50 ng/uL)
0740-0012 Seraseq™ HIV-1 2808-B Reference Material (1x10^6 viral copies) 1x1.0 ml
0740-0011 Seraseq™ HIV-1 2529-B Reference Material (1x10^6 viral copies) 1x1.0 ml
0740-0010 Seraseq™ HIV-1 7384-B Reference Material (1x10^6 viral copies) 1x1.0 ml
0740-0009 Seraseq™ HIV-1 7388-B Reference Material (1x10^6 viral copies) 1x1.0 ml
0740-0008 Seraseq™ HIV-1 CM235-CRF01_AE Reference Material (1x10^6 viral copies) 1x1.0 ml
0740-0007 Seraseq™ HIV-1 I-2496 CRF02_AG Reference Material (1x10^6 viral copies) 1x1.0 ml
0740-0006 Seraseq™ HIV-1 93/US/141-B Reference Material (1x10^6 viral copies) 1x1.0 ml
0740-0005 Seraseq™ HIV-1 93/US/143-B Reference Material (1x10^6 viral copies) 1x1.0 ml
0740-0004 Seraseq™ HIV-1 US1-B Reference Material (1x10^6 viral copies) 1x1.0 ml
0740-0003 Seraseq™ HIV-1 CM237-B Reference Material (1x10^6 viral copies) 1x1.0 ml
0740-0002 Seraseq™ HIV-1 93/US/144-B Reference Material (1x10^6 viral copies) 1x1.0 ml
0740-0001 Seraseq™ HIV-1 BK132-B Reference Material (1x10^6 viral copies) 1x1.0 ml
0730-0003 Seraseq™ Inherited Cancer DNA Mix v1 Purified DNA AF 50% VIAL (200 uL at 50 ng/uL)
0720-0020 Seraseq™ Aneuploidy Negative (Euploid) Reference Material VIAL (1 ml at 20 ng/ ml)
0720-0019 Seraseq™ T21 Aneuploidy Reference Material Reference Material 12% target fetal fraction VIAL (1 ml at 20 ng/ ml)
0720-0018 Seraseq™ T18 Aneuploidy Reference Material Reference Material 12% target fetal fraction VIAL (1 ml at 20 ng/ ml)
0720-0017 Seraseq™ T13 Aneuploidy Reference Material Reference Material 12% target fetal fraction VIAL (1 ml at 20 ng/ ml)
0710-0674 Seraseq™ ctDNA Complete Reference Material WT VIAL (5 ml at 25 ng/ml)
0710-0673 Seraseq™ ctDNA Complete Reference Material AF0.1% VIAL (5 ml at 25 ng/ml)
0710-0672 Seraseq™ ctDNA Complete Reference Material AF0.5% VIAL (5 ml at 25 ng/ml)
0710-0671 Seraseq™ ctDNA Complete Reference Material AF1% VIAL (5 ml at 25 ng/ml)
0710-0669 Seraseq™ ctDNA Complete Reference Material AF5% VIAL (5 ml at 25 ng/ml)
0710-0533 Seraseq™ ctDNA Complete™ Mutation Mix WT VIAL (25 ul at 10 ng/ml)
0710-0532 Seraseq™ ctDNA Complete™ Mutation Mix AF0.1% VIAL (25 ul at 10 ng/ml)
0710-0531 Seraseq™ ctDNA Complete™ Mutation Mix AF0.5% VIAL (25 ul at 10 ng/ml)
0710-0530 Seraseq™ ctDNA Complete™ Mutation Mix AF1% VIAL (25 ul at 10 ng/ml)
0710-0529 Seraseq™ ctDNA Complete™ Mutation Mix AF2.5% VIAL (25 ul at 10 ng/ml)
0710-0528 Seraseq™ ctDNA Complete™ Mutation Mix AF5% VIAL (25 ul at 10 ng/ml)
0710-0408 Seraseq™ Myeloid Mutation DNA Mix Purified DNA AF 5/10/15% VIAL (25 uL at 15 ng/uL)
0710-0407 Seraseq™ Myeloid Fusion RNA Mix Purified RNA VIAL (25 uL at 15 ng/uL)
0710-0208 Seraseq™ ctDNA Reference Material v2 Full-Process, WT VIAL (5 ml at 25 ng/ ml)
0710-0207 Seraseq™ ctDNA Reference Material v2 Full-Process, AF 0.125% VIAL (5 ml at 25 ng/ ml)
0710-0206 Seraseq™ ctDNA Reference Material v2 Full-Process, AF 0.25% VIAL (5 ml at 25 ng/ ml)
0710-0205 Seraseq™ ctDNA Reference Material v2 Full-Process, AF 0.5% VIAL (5 ml at 25 ng/ ml)
0710-0204 Seraseq™ ctDNA Reference Material v2 Full-Process, AF 1% VIAL (5 ml at 25 ng/ ml)
0710-0203 Seraseq™ ctDNA Reference Material v2 Full-Process, AF 2% VIAL (5 ml at 25 ng/ ml)
0710-0144 Seraseq™ ctDNA Mutation Mix v2 Purified DNA WT VIAL (25 uL at 10 ng/uL)
0710-0143 Seraseq™ ctDNA Mutation Mix v2 Purified DNA AF 0.125% VIAL (25 uL at 10 ng/uL)
0710-0142 Seraseq™ ctDNA Mutation Mix v2 Purified DNA AF 0.25% VIAL (25 uL at 10 ng/uL)
0710-0141 Seraseq™ ctDNA Mutation Mix v2 Purified DNA AF 0.5% VIAL (25 uL at 10 ng/uL)
0710-0140 Seraseq™ ctDNA Mutation Mix v2 Purified DNA AF 1% VIAL (25 uL at 10 ng/uL)
0710-0139 Seraseq™ ctDNA Mutation Mix v2 Purified DNA AF 2% VIAL (25 uL at 10 ng/uL)
0710-0097 Seraseq™ Tri-Level Tumor Mutation Purified DNA HC, AF 4/7/10% VIAL (25 uL at 25 ng/uL)
0710-0095 Seraseq™ Tumor Mutation DNA Mix v2 Purified DNA HC, AF 7% VIAL (25 uL at 25 ng/uL)
0710-0094 Seraseq™ Tumor Mutation DNA Mix v2 Purified DNA HC, AF 10% VIAL (25 uL at 25 ng/uL)
1 From 2